Potent and selective aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition

Daniele Fancelli (Lead / Corresponding author), Daniela Berta, Simona Bindi, Alexander Cameron, Paolo Cappella, Patrizia Carpinelli, Cornel Catana, Barbara Forte, Patrizia Giordano, Maria Laura Giorgini, Sergio Mantegani, Aurelio Marsiglio, Maurizio Meroni, Juergen Moll, Valeria Pittalà, Fulvia Roletto, Dino Severino, Chiara Soncini, Paola Storici, Roberto TonaniMario Varasi, Anna Vulpetti, Paola Vianello

Research output: Contribution to journalArticlepeer-review

148 Citations (Scopus)

Abstract

Potent and selective Aurora kinase inhibitors were identified from the combinatorial expansion of the 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole bi-cycle, a novel and versatile scaffold designed to target the ATP pocket of protein kinases. The most potent compound reported in this study had an IC 50 of 0.027 μM in the enzymatic assay for Aur-A inhibition and IC50s between 0.05 μM and 0.5 μM for the inhibition of proliferation of different tumor cell lines.

Original languageEnglish
Pages (from-to)3080-3084
Number of pages5
JournalJournal of Medicinal Chemistry
Volume48
Issue number8
Early online date10 Mar 2005
DOIs
Publication statusPublished - 21 Apr 2005

Keywords

  • Cells
  • Inhibition
  • Kinase inhibitors
  • Peptides and proteins
  • Scaffolds

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Potent and selective aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition'. Together they form a unique fingerprint.

Cite this